Antimetastatic effects of PSK (Krestin), a protein-bound polysaccharide obtained from basidiomycetes: an overview.

PSK, a protein-bound polysaccharide obtained from cultured mycelia of Coriolus versicolor in basidiomycetes, is a biological response modifier, diverse operations of which include an antitumor action. We have previously reviewed recent research which had demonstrated that in animals, PSK has a preventive effect on chemical carcinogen-induced, radiation-induced, and spontaneously developed carcinogenesis (Kobayashi et al., Cancer Epidemiol., Biomarkers & Prev., 2: 271-276, 1993). We now focus on the effects of PSK once the progression of carcinogenesis has begun, and review what is now known of the preventive action of PSK on cancer metastasis. Recent research reports that PSK suppresses pulmonary metastasis of methylcholanthrene-induced sarcomas, human prostate cancer DU145M, and lymphatic metastasis of mouse leukemia P388, and that it has prolonged the survival period in spontaneous metastasis models. PSK also suppresses the metastasis of rat hepatoma AH60C, mouse colon cancer colon 26, and mouse leukemia RL male 1 in artificial metastasis models. PSK influences the steps of cancer metastasis in a number of ways: (a) by suppression of intravasation through the inhibition of tumor invasion, adhesion and production of cell matrix-degrading enzymes; (b) by suppression of tumor cell attachment to endothelial cells through the inhibition of tumor cell-induced platelet aggregation; (c) by suppression of tumor cell migration after extravasation through the inhibition of tumor cell motility; and (d) by suppression of tumor growth after extravasation through the inhibition of angiogenesis, the modulation of cytokine production, and the augmentation of effector cell functions. In addition, PSK has suppressed the malignant progression of mouse tumor cells through superoxide trapping.(ABSTRACT TRUNCATED AT 250 WORDS)

[1]  J. Sakamoto,et al.  Efficacy of immunochemotherapy as adjuvant treatment after curative resection of gastric cancer , 1994, The Lancet.

[2]  T. Fujii,et al.  Interaction of a protein-bound polysaccharide (PSK) with chicken gizzard caldesmon. , 1993, Biological & pharmaceutical bulletin.

[3]  J. Hamada,et al.  Malignant progression of a mouse fibrosarcoma by host cells reactive to a foreign body (gelatin sponge). , 1992, British Journal of Cancer.

[4]  Y. Niitsu,et al.  Effect of KrestinR (PSK) on the Induction of IL-2 Activated Killer Cells , 1992 .

[5]  A. Uchida,et al.  Activation of human natural killer cells by the protein-bound polysaccharide PSK independently of interferon and interleukin 2. , 1992, Immunology letters.

[6]  N. Ogawa,et al.  Randomized, controlled study on adjuvant immunochemotherapy with PSK® in curatively resected colorectal cancer , 1992 .

[7]  林田 康宏.  Effect of lymphokine-activated killer cells on human retinoblastoma cells (Y-79) in vitro : enhancement of the activity by a polysaccharide preparation, krestin , 1992 .

[8]  P. Kumar,et al.  Antiangiogenesis strategies in cancer therapy with special reference to Krestin. , 1992, EXS.

[9]  N. Yamamoto,et al.  Effect of lymphokine-activated killer cells on human retinoblastoma cells (Y-79) in vitro: enhancement of the activity by a polysaccharide preparation, krestin. , 1991, Biochemical and biophysical research communications.

[10]  H. Ishibashi,et al.  [A case of remission in metastatic lung tumor from hepatocellular carcinoma after combined CDDP and PSK therapy]. , 1990, Gan no rinsho. Japan journal of cancer clinics.

[11]  K. Matsushima,et al.  Induction of gene expression and production of immunomodulating cytokines by PSK in human peripheral blood mononuclear cells. , 1990, Lymphokine research.

[12]  D. Mickey,et al.  Combined therapeutic effects of conventional agents and an immunomodulator, PSK, on rat prostatic adenocarcinoma. , 1989, The Journal of urology.

[13]  S. Saji,et al.  [An effect of adjuvant immunochemotherapy using krestin and 5-FU on gastric cancer patients with radical surgery (first report)--a randomized controlled trial by the cooperative study group. Study Group of Immuno-chemotherapy with PSK for Gastric Cancer]. , 1989, Gan to kagaku ryoho. Cancer & chemotherapy.

[14]  F. Okada,et al.  Inhibition of mitomycin C-induced sister-chromatid exchanges in mouse bone marrow cells by the immunopotentiators Krestin and Lentinan. , 1989, Mutation research.

[15]  Y. Yamaguchi,et al.  Blocking of lymphocyte surface binding sites for the soluble suppressor factor by protein-bound polysaccharide, PSK. , 1989, International journal of immunopharmacology.

[16]  H. Akashi,et al.  INTERACTION OF PROTEIN-BOUND POLYSACCHARIDE (PSK) WITH MYOSIN SUBFRAGMENT-1 (S-I): IDENTIFICATION OF PSK-BINDING REGION IN THE S-1 MOLECULE , 1988 .

[17]  S. Takashima,et al.  [Clinical effect of postoperative adjuvant immunochemotherapy with the FT-207 suppository and PSK in colorectal cancer patients. Colorectal Cancer Chemotherapy Group in Hokuriku]. , 1988, Gan to kagaku ryoho. Cancer & chemotherapy.

[18]  K. Konno,et al.  Effects of protein-bound polysaccharide preparation(PSK) in small cell carcinoma of the lung. , 1988 .

[19]  M. Katano,et al.  [A suppressive effect of PSK, a protein-bound polysaccharide preparation, on tumor growth: a new effect of PSK on cell motility]. , 1987, Gan to kagaku ryoho. Cancer & chemotherapy.

[20]  D. Sabolović,et al.  Effect of a protein bound polysaccharide (PS-K) on tumor development and infections in splenectomized rats and mice. , 1986, International journal of immunopharmacology.

[21]  T. Kishimoto,et al.  [Experimental study on immunochemotherapy (PSK, CQ) in rat bladder cancer (BC-47)]. , 1985, Gan to kagaku ryoho. Cancer & chemotherapy.

[22]  K. Hirose,et al.  Cloning of sequences induced and suppressed by administration of PSK, antitumor protein-bound polysaccharide. , 1985, Biochemical and biophysical research communications.

[23]  M. Hosokawa,et al.  Therapeutic effects of PS-K and busulfan on the recurrent and metastatic diseases after the surgical removal of 3-methylcholanthrene-induced autochthonous tumors in C57BL/6 mice. , 1985, Japanese journal of cancer research : Gann.

[24]  M. Watanabe,et al.  Effect of PSK on interferon production in tumor-bearing mice. , 1984, Journal of clinical & laboratory immunology.

[25]  Y. Minamishima,et al.  Protective effect of biological response modifiers on murine cytomegalovirus infection , 1984, Journal of virology.

[26]  T. Fujii,et al.  Effect of protein-bound polysaccharide (PS-K) on microtubule polymerization. , 1983, Chemical & pharmaceutical bulletin.

[27]  K. Nomoto,et al.  Effects of PSK on specific tumor immunity to syngeneic tumor cells. , 1983, Journal of clinical & laboratory immunology.

[28]  M. J. Ehrke,et al.  The effect of PS-K, a protein bound polysaccharide, on immune responses against allogeneic antigens. , 1983, International journal of immunopharmacology.

[29]  W. Takiyama,et al.  Inhibitory effects of immunopotentiators on the enhancement of lung metastases induced by operative stress in rats. , 1982, Gan.